Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink.

Wilding, J; Godec, T; Khunti, K; Pocock, S; Fox, R; Smeeth, L; Clauson, P; Fenici, P; Hammar, N; Medina, J; (2018) Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink. BMC medicine, 16 (1). p. 116. ISSN 1741-7015 DOI: https://doi.org/10.1186/s12916-018-1085-8

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/s12916-018-1085-8

Abstract

Share

Download

Filename: Changes in HbA1c and weight_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar